George Scott Uzzell, Chief Executive Officer and Director of Helen of Troy Ltd, filed a statement of changes in beneficial ownership on September 4, 2026, disclosing a share withholding transaction dated September 2, 2026.
Japan Post Holdings Co., Ltd. filed a Form 4 with the SEC on September 4, 2026, disclosing a sale of Aflac Incorporated (NYSE:AFL) common stock executed on September 2, 2026, pursuant to a Rule 10b5-1 trading plan.
Alyssa H. Fontaine, Executive Vice President, General Counsel and Chief Risk Officer of Tompkins Financial Corp (NYSE:TMP), filed a Form 4 on September 3, 2026, reporting two common stock transactions dated September 2, 2026, stemming from the exercise of Stock Appreciation Rights.
Donegal Mutual Insurance Co filed a Form 4 with the U.S. Securities and Exchange Commission on September 4, 2026, disclosing two open-market purchases of Class A Common Stock in Donegal Group Inc (NASDAQ:DGICA) on September 2 and September 3, 2026.
Director Maurice Tulloch filed an amended statement of changes in beneficial ownership with the SEC on September 4, 2026, correcting a prior filing dated July 6, 2026, to accurately reflect shares withheld for taxes in connection with a July 1, 2026 stock award.
Vincent Anthony Viozzi, Senior Vice President and Chief Investment Officer of Donegal Group Inc, filed a Form 4 with the SEC on September 4, 2026, reporting the sale of 2,282 shares of Class A Common Stock on September 3, 2026.
Director Barry Craig Huber filed a Form 4 with the SEC on September 4, 2026, disclosing the exercise of stock options and a same-day sale of Class A Common Stock of Donegal Group Inc on September 3, 2026.
A Form 4 filed on September 4, 2026, with the U.S. Securities and Exchange Commission discloses that Patrick Edward Ahern, Executive Vice President of Associated Banc-Corp (NYSE:ASB), sold shares of the company's common stock on September 3, 2026.
Director Dian C. Taylor of Artesian Resources Corp filed a Form 4 on September 4, 2026, disclosing the sale of Class A Non-voting Common Stock across two transactions on September 2 and September 3, 2026.
A Form 4 filed on September 4, 2026, disclosed that Timothy Schmid, Executive Vice President and Worldwide Chairman of MedTech at Johnson & Johnson, exercised stock options and sold the resulting shares on September 2, 2026.